.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Deloitte
Express Scripts
AstraZeneca
Harvard Business School
Cantor Fitzgerald
Argus Health
Citi
Chubb
Fuji

Generated: June 27, 2017

DrugPatentWatch Database Preview

SIROLIMUS Drug Profile

« Back to Dashboard

What is the patent landscape for Sirolimus, and when can generic versions of Sirolimus launch?

Sirolimus is a drug marketed by Zydus Pharms Usa Inc and Dr Reddys Labs Ltd and is included in two NDAs.

The generic ingredient in SIROLIMUS is sirolimus. There are eighteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the sirolimus profile page.

Summary for Tradename: SIROLIMUS

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list4
Bulk Api Vendors: see list43
Clinical Trials: see list471
Patent Applications: see list9,683
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SIROLIMUS at DailyMed

Pharmacology for Tradename: SIROLIMUS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc
SIROLIMUS
sirolimus
TABLET;ORAL201676-003Jan 8, 2014ABRXNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
SIROLIMUS
sirolimus
TABLET;ORAL201578-001Oct 27, 2014ABRXNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
SIROLIMUS
sirolimus
TABLET;ORAL201578-002Oct 27, 2014ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
QuintilesIMS
Johnson and Johnson
Federal Trade Commission
McKinsey
McKesson
Accenture
Queensland Health
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot